drugset / Trial / NCT00568607

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

NCT00568607

Phase 2 Unknown 60 enrolled Fudan University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of DICE in the patients with NK/T cell lymphoma.

Timeline

Start
2007-03
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DDP Unknown 20 mg/m2
Subject DXM Unknown 40 mg
Subject Etoposide Small molecule 75 mg/m2
Subject IFO Unknown 1200 mg/m2
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule 400 mg

Indications